Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-19

FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for a fixed-dose combination of amlodipine and valsartan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)